Shareholder Alert: AF&T Announces That It Has Been Retained to Investigate Claims on Behalf of Investors in Sunesis Pharmaceu...
July 24 2015 - 11:38AM
Business Wire
Abraham, Fruchter & Twersky, LLP (“AF&T” or the “Firm”)
has been retained to investigate claims which may be brought on
behalf of investors who purchased Sunesis Pharmaceuticals, Inc.
(“SNSS” or the “Company”) (NASDAQ: SNSS) during the period of March
12, 2015 through July 23, 2015.
On July 23rd, SNSS surprised investors by announcing that the
Food and Drug Administration (“FDA”) would not support the filing
of a New Drug Application (“NDA”) based upon the data collected in
the Company’s Phase 3 trials because the data did not reach a level
of statistical significance. In reaction to this announcement, on
July 24th, the stock of SNSS plunged in value by more than 70% to
trade at approximately $1.00 per share from its previous closing
price of $3.47 per share.
If you would like to discuss this investigation, or if you have
any questions concerning your rights as a potential lead plaintiff,
you may contact: Jeffrey S. Abraham or Philip T. Taylor of Abraham,
Fruchter & Twersky, LLP toll free at (800) 440-8986, or via
e-mail at jabraham@aftlaw.com or ptaylor@aftlaw.com.
Abraham, Fruchter & Twersky, LLP, which is based in New York
and has an office in California, has extensive experience in
shareholder and securities class action cases, and the firm has
been ranked among the leading class action law firms in terms of
recoveries achieved by a survey of class action law firms conducted
by Institutional Shareholder Services.
Attorney Advertising. Prior Results Do Not Guarantee A Similar
Outcome.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150724005548/en/
Abraham, Fruchter & Twersky, LLPJeffrey S. AbrahamPhilip T.
TaylorOne Penn Plaza, Suite 2805New York, N.Y. 10119Telephone:
800-440-8986
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2023 to Jul 2024